Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polycythemia Vera × Hydroxyurea × Clear all

Phase

Phase 3 6 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Meningioma 7 Brain Neoplasms 6 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Leukemia, Myeloid, Acute 4 Neoplasms 3 Glioblastoma 3 Stomach Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Thyroid Carcinoma, Anaplastic 1 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Nasopharyngeal Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1

Interventions

fludarabine phosphate 17 Cyclophosphamide 15 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 10 ruxolitinib 9 Mycophenolic Acid 9 Busulfan 9 Tacrolimus 8 fludarabine 7 Radiotherapy 5 Methotrexate 5 Cyclosporine 5 Aspirin 5 Melphalan 4 Imatinib Mesylate 4 Biopsy 4 Antilymphocyte Serum 4 peginterferon alfa-2a 3 givinostat hydrochloride 3 givinostat 3 Stem Cell Transplantation 3 Specimen Handling 3 Prednisone 3 Decitabine 3 bomedemstat 2 Surveys and Questionnaires 2 Methylprednisolone 2 Lenalidomide 2 Filgrastim 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00928707 2019-10-31

PV

Italfarmaco

Phase 2 Completed

45 enrolled 10 charts

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡